NERM
PRAH

New England Research & Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

New England Research & Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,371
Closed -$708K – 172
2019
Q4 		$708K Sell
6,371
-750
-11% -$77.1K 0.47% 76
2019
Q3 		$707K Sell
7,121
-950
-12% -$94.3K 0.51% 71
2019
Q2 		$800K Buy
+8,071
New +$770K 0.54% 66

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

New England Research & Management's PRAH Position: Q1 2020 in Review

New England Research & Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 6,371 shares — an estimated $708K sold.

New England Research & Management first reported a position in PRAH in Q2 2019 and held it in 3 quarters. The position peaked at $800K in Q2 2019. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • New England Research & Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • New England Research & Management sold 6,371 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $708K.
  • New England Research & Management first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 3 quarters.
  • New England Research & Management's PRA Health Sciences, Inc. position peaked at $800K in Q2 2019.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on New England Research & Management's 13F filing for Q1 2020, filed 15 Jun 2020.